以原发性肺动脉高压为表现的NDUFAF2基因突变1例

颜晓丹, 陈艳艳, 陶莉

中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (5) : 609-612.

PDF(720 KB)
HTML
PDF(720 KB)
HTML
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (5) : 609-612. DOI: 10.7499/j.issn.1008-8830.2411150
病例报告

以原发性肺动脉高压为表现的NDUFAF2基因突变1例

作者信息 +

NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report

Author information +
文章历史 +

摘要

男性患儿,生后1 d,因持续性肺动脉高压入院,经积极治疗后肺动脉高压仍进行性加重,且早期出现右心衰竭。家系全外显子组测序提示患儿存在NDUFAF2基因复合杂合变异c.192del和c.192_193del,分别遗传自父母,符合美国医学遗传学与基因组学学会的致病性变异标准。尸检结果提示肺动脉扩张及心肌肥厚,肺组织电镜检查未见肺泡毛细血管发育不良。NDUFAF2基因突变与线粒体复合体Ⅰ缺乏症相关,该病例首次将其与新生儿原发性肺动脉高压关联,为原发性肺动脉高压的遗传病因提供新证据,并强调遗传学及病理学在新生儿重症疾病研究中的重要性。

Abstract

A male neonate was admitted on postnatal day 1 with persistent pulmonary hypertension. Despite aggressive treatment, the pulmonary hypertension progressively worsened, leading to early right heart failure. Whole-exome sequencing of the family revealed compound heterozygous mutations c.192del and c.192_193del in the NDUFAF2 gene, inherited from each parent, meeting the pathogenic variant criteria of the American College of Medical Genetics and Genomics. Autopsy showed pulmonary artery dilation and myocardial hypertrophy, with no evidence of alveolar capillary dysplasia on lung tissue electron microscopy. Mutations in the NDUFAF2 gene are associated with mitochondrial complex I deficiency. This is the first reported case associating NDUFAF2 mutations with neonatal primary pulmonary hypertension, providing new genetic evidence for this condition and highlighting the importance of genetic and pathological studies in severe neonatal diseases.

关键词

原发性肺动脉高压 / NDUFAF2基因 / 新生儿

Key words

Primary pulmonary hypertension / NDUFAF2 gene / Neonate

引用本文

导出引用
颜晓丹, 陈艳艳, 陶莉. 以原发性肺动脉高压为表现的NDUFAF2基因突变1例[J]. 中国当代儿科杂志. 2025, 27(5): 609-612 https://doi.org/10.7499/j.issn.1008-8830.2411150
Xiao-Dan YAN, Yan-Yan CHEN, Li TAO. NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(5): 609-612 https://doi.org/10.7499/j.issn.1008-8830.2411150

参考文献

1
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
2
Mukherjee D, Konduri GG. Pediatric pulmonary hypertension: definitions, mechanisms, diagnosis, and treatment[J]. Compr Physiol, 2021, 11(3): 2135-2190. PMCID: PMC8289457. DOI: 10.1002/cphy.c200023 .
3
Grady RM, Eghtesady P. Potts shunt and pediatric pulmonary hypertension: what we have learned[J]. Ann Thorac Surg, 2016, 101(4): 1539-1543. DOI: 10.1016/j.athoracsur.2015.08.068 .
4
Latus H, Apitz C, Moysich A, et al. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies[J]. J Heart Lung Transplant, 2014, 33(5): 542-546. DOI: 10.1016/j.healun.2014.01.860 .
5
Lancaster TS, Shahanavaz S, Balzer DT, et al. Midterm outcomes of the Potts shunt for pediatric pulmonary hypertension, with comparison to lung transplant[J]. J Thorac Cardiovasc Surg, 2021, 161(3): 1139-1148. DOI: 10.1016/j.jtcvs.2020.10.163 .
6
Hayes D, Jennerich AL, Coleman RD, et al. Interventional strategies for children with progressive pulmonary hypertension despite optimal therapy: an official American Thoracic Society clinical practice guideline[J]. Am J Respir Crit Care Med, 2025, 211(2): 157-173. PMCID: PMC11812548. DOI: 10.1164/rccm.202410-1901ST .
7
Singh Y, Lakshminrusimha S. Pathophysiology and management of persistent pulmonary hypertension of the newborn[J]. Clin Perinatol, 2021, 48(3): 595-618. PMCID: PMC8351908. DOI: 10.1016/j.clp.2021.05.009 .
8
Lambert M, Mendes-Ferreira P, Ghigna MR, et al. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload[J]. Cardiovasc Res, 2021, 117(12): 2474-2488. DOI: 10.1093/cvr/cvab016 .
9
Haarman MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, et al. The genetic epidemiology of pediatric pulmonary arterial hypertension[J]. J Pediatr, 2020, 225: 65-73.e5. DOI: 10.1016/j.jpeds.2020.05.051 .
10
Herzer M, Koch J, Prokisch H, et al. Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect[J]. Neuropediatrics, 2010, 41(1): 30-34. DOI: 10.1055/s-0030-1255062 .
11
Schlehe JS, Journel MS, Taylor KP, et al. The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress[J]. Neurobiol Dis, 2013, 58: 57-67. PMCID: PMC3748239. DOI: 10.1016/j.nbd.2013.05.007 .
12
Gallo G, Forte M, Cotugno M, et al. Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension[J]. Mol Med, 2023, 29(1): 107. PMCID: PMC10410816. DOI: 10.1186/s10020-023-00701-x .
13
MacMAHON HE. Congenital alveolar dysplasia; a developmental anomaly involving pulmonary alveoli[J]. Pediatrics, 1948, 2(1): 43-57.
14
Chan CD, Niyogi A, Jaffray B, et al. Lung biopsy in children: when is it useful?[J]. Arch Dis Child, 2021, 106(3): 291-293. DOI: 10.1136/archdischild-2019-318443 .
15
Swinton CH, Weiner J, Okah FA. The neonatal autopsy: can it be revived?[J]. Am J Perinatol, 2013, 30(9): 739-744. DOI: 10.1055/s-0032-1332798 .

作者贡献声明

颜晓丹负责文章设计、撰写及病例收集;陈艳艳和陶莉负责病例筛选和审核。


编委: 王颖

版权

版权所有 © 2023中国当代儿科杂志
PDF(720 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/